Share these talks and lectures with your colleagues
Invite colleaguesWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo talk
This is a limited length demo talk; you may
login
or review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Definition
- Complications associated with SSc
- Sclerodactyly
- Raynaud’s phenomenon
- Dilated capillaries
- Calcinosis
- Telangiectasias
- Interstitial lung disease
- Epidemiology
- Pediatric scleroderma
- Genetics
- The disease process in systemic sclerosis
- Disease pathogenesis
- Humoral immune system alterations
- Tissue inflammation in early disease
- Cellular immune response
- Fibrosis
- Molecular mechanisms in SSc
- Systemic sclerosis classification criteria
- Early diagnosis of systemic sclerosis
- Screening and diagnosis
- Biomarkers
- Clinical consequences: fibrosis
- Skin Fibrosis
- The modified Rodnan Skin Score (mRSS)
- Skin thickness progression rate
- Effectiveness of therapies
- Immunomodulatory therapies
- Antifibrotic therapies
- Targeted immunosuppression
- Disease modification
- New targeted therapies for SSc fibrosis
Topics Covered
- Complications associated with systemic sclerosis
- The disease process in systemic sclerosis
- Disease pathogenesis
- Humoral immune system alterations
- Fibrosis
- Molecular mechanisms in systemic sclerosis
- Systemic sclerosis classification criteria
- Biomarkers
- The modified Rodnan Skin Score
- Skin thickness progression rate
- Effectiveness of therapies
- New targeted therapies for SSc fibrosis
Links
Categories:
Therapeutic Areas:
Talk Citation
Derk, C. (2018, September 27). Systemic sclerosis: an update [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 14, 2019, from https://hstalks.com/bs/3819/.Publication History
Financial Disclosures
- Prof. Chris Derk has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Systemic sclerosis: an update
Published on September 27, 2018
36 min